Bespoke treatment: Drivers beware!

Sharon Pattison, John R. Zalcberg

Research output: Contribution to journalArticleOtherpeer-review

1 Citation (Scopus)


Significant progress has been made in the identification of molecular targets and targeted therapy is becoming a realistic option for patients with tumors for which potential driver mutations are identified. We present a case that highlights that the identification of a potential driver mutation does not confirm it as a key mutational event in every case and emphasizes the need for ongoing research to enable therapy to be more accurately directed for the benefit of patients.

Original languageEnglish
Pages (from-to)378-380
Number of pages3
JournalAsia-Pacific Journal of Clinical Oncology
Issue number4
Publication statusPublished - 1 Dec 2014
Externally publishedYes

Cite this